Tudor Investment Corp’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-36,975
| Closed | -$169K | – | 2258 |
|
2025
Q1 | $169K | Buy |
+36,975
| New | +$169K | ﹤0.01% | 1421 |
|
2024
Q4 | – | Sell |
-41,544
| Closed | -$201K | – | 2141 |
|
2024
Q3 | $201K | Sell |
41,544
-1,105
| -3% | -$5.35K | ﹤0.01% | 1412 |
|
2024
Q2 | $208K | Buy |
42,649
+925
| +2% | +$4.51K | ﹤0.01% | 1361 |
|
2024
Q1 | $554K | Buy |
+41,724
| New | +$554K | ﹤0.01% | 1074 |
|
2023
Q4 | – | Sell |
-31,744
| Closed | -$421K | – | 1992 |
|
2023
Q3 | $421K | Buy |
31,744
+901
| +3% | +$11.9K | ﹤0.01% | 1166 |
|
2023
Q2 | $578K | Sell |
30,843
-8,931
| -22% | -$167K | 0.01% | 1085 |
|
2023
Q1 | $574K | Buy |
39,774
+13,489
| +51% | +$195K | 0.01% | 1095 |
|
2022
Q4 | $509K | Buy |
+26,285
| New | +$509K | 0.01% | 1110 |
|
2022
Q2 | – | Sell |
-24,216
| Closed | -$553K | – | 1984 |
|
2022
Q1 | $553K | Buy |
+24,216
| New | +$553K | 0.01% | 1064 |
|
2021
Q3 | – | Sell |
-7,904
| Closed | -$476K | – | 1996 |
|
2021
Q2 | $476K | Buy |
+7,904
| New | +$476K | 0.01% | 1128 |
|